tiprankstipranks
Advertisement
Advertisement

CTSO Stock Latest News

Cytosorbents Earnings Call Balances Progress and Pressure
Company AnnouncementsCytosorbents Earnings Call Balances Progress and Pressure
10h ago
CTSO
Cytosorbents Earnings Call Balances Progress And Pressure
PremiumCompany Announcements
Cytosorbents Earnings Call Balances Progress And Pressure
6d ago
CTSO
CytoSorbents reports Q1 adjusted EPS (5c) vs. (6c) last year
PremiumThe Fly
CytoSorbents reports Q1 adjusted EPS (5c) vs. (6c) last year
7d ago
CTSO
CTSO Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CTSO Earnings this Week: How Will it Perform?
17d ago
CTSO
CytoSorbents Receives Nasdaq Extension to Regain Compliance
PremiumCompany Announcements
CytoSorbents Receives Nasdaq Extension to Regain Compliance
2M ago
8K
CTSO
Cytosorbents’ Earnings Call Balances Progress and Risk
PremiumCompany AnnouncementsCytosorbents’ Earnings Call Balances Progress and Risk
2M ago
CTSO
CytoSorbents: Neutral Stance as U.S. DrugSorb-ATR Opportunity Offsets Near-Term Execution and Regulatory Risks
Premium
Ratings
CytoSorbents: Neutral Stance as U.S. DrugSorb-ATR Opportunity Offsets Near-Term Execution and Regulatory Risks
2M ago
CTSO
CytoSorbents Narrows Losses Amid Strategic Shift and Growth
Premium
Company Announcements
CytoSorbents Narrows Losses Amid Strategic Shift and Growth
2M ago
8K
CTSO
CytoSorbents reports Q4 adjusted EPS (7c) vs. (3c) last year
PremiumThe Fly
CytoSorbents reports Q4 adjusted EPS (7c) vs. (3c) last year
2M ago
CTSO
CTSO Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CTSO Upcoming Earnings Report: What to Expect?
2M ago
CTSO
CytoSorbents sees Q4 revenue $9.2M, consensus $9.85M
PremiumThe Fly
CytoSorbents sees Q4 revenue $9.2M, consensus $9.85M
4M ago
CTSO
CytoSorbents sees FY25 revenue $37M, consensus $37.67M
PremiumThe Fly
CytoSorbents sees FY25 revenue $37M, consensus $37.67M
4M ago
CTSO
Cytosorbents Corp’s Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsCytosorbents Corp’s Earnings Call: Growth Amid Challenges
6M ago
CTSO
CytoSorbents price target lowered to 75c from $1 at H.C. Wainwright
Premium
The Fly
CytoSorbents price target lowered to 75c from $1 at H.C. Wainwright
6M ago
CTSO
CytoSorbents Reports Strong Q3 2025 Growth and Strategic Advances
Premium
Company Announcements
CytoSorbents Reports Strong Q3 2025 Growth and Strategic Advances
6M ago
CTSO
CytoSorbents reports Q3 adjusted EPS (4c), consensus (5c)
PremiumThe Fly
CytoSorbents reports Q3 adjusted EPS (4c), consensus (5c)
6M ago
CTSO
CytoSorbents implemented workforce and cost reduction program
PremiumThe Fly
CytoSorbents implemented workforce and cost reduction program
6M ago
CTSO
CTSO Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CTSO Upcoming Earnings Report: What to Expect?
6M ago
CTSO
Cytosorbents Corp’s Latest Study Update: A Game Changer in Critical Care?
PremiumCompany Announcements
Cytosorbents Corp’s Latest Study Update: A Game Changer in Critical Care?
7M ago
CTSO
CytoSorbents’ STAR Registry: A Closer Look at the Latest Clinical Study Update
PremiumCompany AnnouncementsCytoSorbents’ STAR Registry: A Closer Look at the Latest Clinical Study Update
7M ago
CTSO
Cytosorbents Faces Nasdaq Non-Compliance Notice
Premium
Company Announcements
Cytosorbents Faces Nasdaq Non-Compliance Notice
8M ago
8K
CTSO
CytoSorbents provides DrugSorb-ATR regulatory update
Premium
The Fly
CytoSorbents provides DrugSorb-ATR regulatory update
8M ago
CTSO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >